Clinical Trial: Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-cystic Fibrosis Bronchiectasis
Study Type: INTERVENTIONAL
Official Title: Evaluating Trikafta for the Treatment of Patients With Non-cystic Fibrosis Bronchiectasis (NCFBE)
Brief Summary:
Study participants with non-cystic fibrosis bronchiectasis will be given Trikafta for four weeks.The researchers will monitor clinical endpoints, quality of life, and weight.Additionally, cutaneous punch biopsy material will be collected from each participant to test cellular response to Trikafta.
Read more